A Phase 2 Randomized Controlled Multisite Study Using Omalizumab-facilitated Rapid Desensitization to Test Continued vs Discontinued Dosing in Multifood Allergic Individuals

BACKGROUND: As there is limited data on the sustainability of desensitization of multifood-oral immunotherapy (multifood-OIT), we conducted a multisite multifood-OIT study to compare the efficacy of successful desensitization with sustained dosing vs discontinued dosing after multifood-OIT. METHODS:...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:EClinicalMedicine
المؤلفون الرئيسيون: Andorf, Sandra, Purington, Natasha, Kumar, Divya, Long, Andrew, O'Laughlin, Katherine L., Sicherer, Scott, Sampson, Hugh, Cianferoni, Antonella, Whitehorn, Terri Brown, Petroni, Daniel, Makhija, Melanie, Robison, Rachel G., Lierl, Michelle, Logsdon, Stephanie, Desai, Manisha, Galli, Stephen J., Rael, Efren, Assa'ad, Amal, Chinthrajah, Sharon, Pongracic, Jacqueline, Spergel, Jonathan M., Tam, Jonathan, Tilles, Stephen, Wang, Julie, Nadeau, Kari
التنسيق: Artigo
اللغة:Inglês
منشور في: Elsevier 2019
الموضوعات:
Research Paper
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC6537534/
https://ncbi.nlm.nih.gov/pubmed/31193674
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eclinm.2018.12.006
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة